Aspira Pathlab & Diagnostics Ltd - 540788 - Statement Of Investor Complaints For The Quarter Ended September 2019
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0000 Name of the Signatory :- Mamta MavDesignation :- Company Secretary and Compliance Officer Aspira Pathlab & Diagnostics Ltd - 540788 - Closure of Trading Window
The financial results of the Company for the quarter ending September 30, 2019 will be declared in accordance with Regulation 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. We write to inform you that in view of the foregoing and in accordance with the Code of Conduct for prevention of Insider trading framed by the Company, the Trading Window for Designated Persons will be closed for the period from September 30, 2019 till 48 hours after the declaration of financial results to Stock Exchange. Thanking you. Aspira Pathlab & Diagnostics Ltd - 540788 - Disclosure of Voting results of AGM (Regulation 44(3) of SEBI (LODR) Regulations, 2015)
Aspira Pathlab & Diagnostics Ltd has informed BSE regarding the details of Voting results of AGM, under Regulation 44(3) of SEBI (LODR) Regulations, 2015. Kindly Click here Aspira Pathlab & Diagnostics Ltd - 540788 - Voting Result Of Forty Sixth Annual General Meeting Of The Company Held On September 21, 2019
We wish to inform you that the 46th Annual General Meeting (AGM) of the Company was held on Saturday, September 21, 2019 at Lantana Hall, Ghatkopar Jolly Gymkhana, Jugaldas Modi Marg, (Kirol Road), Ghatkopar (West), Mumbai- 400086, Maharashtra. In terms of the Consolidated Report of the Scrutinizer, Mr. S.K. Pandey, Practicing Company Secretaries, on the remote e-voting and voting at the AGM through Poll conducted, all the Resolutions set out in the Notice of the 46th AGM are validly passed with the requisite majority. In accordance with the Regulation 44 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015, the consolidated voting results of the business transacted at the AGM and the consolidated report of scrutinizers are enclosed as Annexure I and Annexure II. Aspira Pathlab & Diagnostics Ltd - 540788 - Shareholder Meeting / Postal Ballot-Outcome of AGM
We wish to inform you that the 46th Annual General Meeting of the Members of the Company was held on Saturday, September 21, 2019 at 11.00 am at Lantana Hall, Ghatkopar Jolly Gymkhana, Jugaldas Modi Marg, (Kirol Road), Ghatkopar (West), Mumbai- 400086, Maharashtra. Pursuant to Regulation 30 read with Para A of Part A in schedule III of the SEBI (Listing Obligation and Disclosure Requirements) Regulations, 2015, we are enclosing a summary of the proceedings of the Company's Forty Sixth Annual General Meeting. We request you to disseminate the above information on your website. Aspira Pathlab & Diagnostics Ltd - 540788 - Newspaper Clippings - Notice Of Annual General Meeting And Record Date
Pursuant to Regulation 47(1) of Listing Regulations, we enclose herewith copies of the public notice of 46th Annual General Meeting scheduled to be held on September 21, 2019 and Record date published on August 30, 2019 in 'Business Standard' in English language and in Mumbai Lakshyadeep in Marathi language. Kindly take the same on record. Aspira Pathlab & Diagnostics Ltd - 540788 - Annual General Meeting To Be Held On September 21, 2019
This is to inform you that the 46th Annual General Meeting of the Members of the Company is scheduled to be held on Saturday, September 21, 2019 at 11.00 am at Lantana Hall, Ghatkopar Jolly Gymkhana, Jugaldas Modi Marg, (Kirol Road), Ghatkopar (West), Mumbai- 400086, Maharashtra. Pursuant to Regulation 34 (1) of Listing Regulations, we enclose herewith the Annual Report of the Company for the Financial Year 2018-19, including the Notice of the 46th Annual General Meeting scheduled to be held on September 21, 2019. The same is also available on the website of the Company at the following weblink : https://www.aspiradiagnostics.com/wp-content/uploads/2019/08/Annual-Report-2018-19.pdf The Company will provide to its members the facility to cast their vote(s) on all resolutions set out in the Notice by electronic means ('e-voting'). The e-voting communication giving instructions for e-voting, being sent along with the integrated Annual Report, is also attached. Aspira Pathlab & Diagnostics Ltd - 540788 - Reg. 34 (1) Annual Report
This is to inform you that the 46th Annual General Meeting of the Members of the Company is scheduled to be held on Saturday, September 21, 2019 at 11.00 am at Lantana Hall, Ghatkopar Jolly Gymkhana, Jugaldas Modi Marg, (Kirol Road), Ghatkopar (West), Mumbai- 400086, Maharashtra. Pursuant to Regulation 34 (1) of Listing Regulations, we enclose herewith the Annual Report of the Company for the Financial Year 2018-19, including the Notice of the 46th Annual General Meeting scheduled to be held on September 21, 2019. The same is also available on the website of the Company at the following weblink : https://www.aspiradiagnostics.com/wp-content/uploads/2019/08/Annual-Report-2018-19.pdf Aspira Pathlab & Diagnostics Ltd - 540788 - Book Closure For The Purpose Of 46Th Annual General Meeting
With reference to the captioned subject, we wish to inform you that the register of members and share transfer book of the company will be closed from Sunday, September 15, 2019 to Saturday, September 21, 2019 (both days inclusive). Aspira Pathlab & Diagnostics Ltd - 540788 - Announcement under Regulation 30 (LODR)-Preferential Issue
In relation to the proposed fund raising by preferential allotment of equity shares by the Aspira Pathlab & Diagnostics Limited (the "Company'). In furtherance to our letter dated July 31, 2019, with respect to the issuance of Equity Shares on a preferential basis, we wish to inform you that the board of directors of the Company (the "Board") at its meeting held on August 21, 2019, subject to the approval of the shareholders of the Company, has approved the issue and allotment of up to 38,00,000 (Thirty Eight Lakhs) Equity Shares of face value of INR 10/- each, at an issue price Rs. 26 (Rupees Twenty Six) including premium of Rs. 16 (Rupees Sixteen) to strategic investors not forming part of promoter or promoter group, on a preferential basis, on terms and conditions as approved by the Board. We would also like to inform that an Annual General Meeting of the Members of the Company will be held on 21th September, 2019 for seeking their approval for the above issue of shares.